Schedule 13D ownership disclosure

Coherus Oncology Inc

Security class unavailable · CUSIP: 19249H103

Event date: 2014-11-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,055,055
Percent of class
9.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-14-081362
Form type
SC 13D
Filer
Coherus Oncology, Inc.
CIK
CIK 1512762
Filed
Nov 17, 2014
Reporting period
Nov 12, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub